EXAS Poor Due Dilgence

I purchased EXAS after reading about it here and taking a look at the investor page and reading a few write ups.

I have read some more. The finacials are not great. But reading the bull and bear cases I cannot get clarity.

I am wondering if anyone can make a clear bull or bear case for EXAS.

Thanks
Qazulight

This was another one shorted by Andrew Left. He claimed that another company had or was releasing a better product for the same thing.

http://citronresearch.com/citron-research-exposes-exact-scie…
http://citronresearch.com/not-believe-citron-research/

This was another one shorted by Andrew Left. He claimed that another company had or was releasing a better product for the same thing.

Considering his recent record, that is almost a bull case.

Cheers
Qazulight

That report was from may and stock has done very well since

Andrew Left isn’t always wrong, and it seems like his more recent shorts are based on sensationalism or misunderstanding. His case against EXAS made more sense to me than his shorts of UBNT and SHOP.

One problem with shorting is that you can be right and still not make money.

Jim Chanos and Scott Fearon are two (mostly) short-side investors whose opinions are worth checking out.

1 Like

Andrew Left isn’t always wrong
I am still looking for an advisor who is always wrong, nearly as valuable as one who is always right.

4 Likes

Here I’m cross-pollinating our threads, citing the discussion of FMI, which could well come up with a DNA test for colon cancer that would supersede the test from EXAS.

2 Likes